YSP has continuously delivered good results in the past 2 quarters. This trend is expected to continue given its new facilities contribution started kick-in last year.
Turnover 31 Mar 15 - 59.3m ( + 15% ) 31 Dec 14 - 54.9m ( + 13% ) 30 Sep 14 - 49.8m ( + 7% ) 30 Jun 14 - 46.1m 31 Mar 14 - 51.4m 31 Dec 13 - 48.8m
Profit (EPS) 31 Mar 15 - 6.98 cents ( + 70% ) 31 Dec 14 - 5.27 cents ( + 72% ) 30 Sep 14 - 2.30 cents ( -27% ) 30 Jun 14 - 0.72 cents 31 Mar 14 - 4.10 cents 31 Dec 13 - 3.06 cents
LTH was the only institutional investor as shown in AR 2014. The remaining held by LTH stands at 7.8 million shares after the disposal recently. It's a small value for syndicates or other institutional investors to absorb the shares even though LTH intends to sell it all.
still in correction price. LTH selling share, havent finish yet. think will drop below $ 2.00 tomorrow. ex date for div rm0.065 still long from now. investors still got chance to collect Yspsah below rm2.00.
Securities frims are busy accumulating the shares. They dare not dish out a research report for YSPSAH. It's good to see LTH keep reducing its stakes. Time to collect more.
For our operations abroad, the new manufacturing plant in Lippo Cikarang, Jawa Barat, Indonesia is on schedule to commence operation to produce oral solid dosage products and cream and suppository products in the new financial year. Approval of the HVAC (heating, ventilation, and air conditioning) System has been received from Indonesia’s Food and Drugs Monitoring Agency (BPOM). Interior renovation work in the production area is in progress and is expected to be completed by mid-2014.
Icon8888. The growth story is quite reliable since revenue has been increasing for the past few years. It had never achieved turnover of 60m except last quarter. Apparently, additional contribution is derived from new facility in Indonesia.
Thanks Up_Down. This stock now commands lowest TTM PE among Hovid, Pharma, CCMDBIO, AHEALTH. Time will come for rerating, when big shark accumulates enough shares. Hahaha.
From Annual Report 2014, it mentions that Indonesia new manufacturing is SCHEDULED to complete in 2015 Q1, and EXPECTED to be ready for inspection by authorities in 2015 Q3.
So I think Indonesia plant has yet to commence operation and net yet contribution to YSP performance, right?
I think they can only commence operation in Indonesia after being granted approval by authorities.
The research report would probably come out after YSP has announced good 2qtr results. By that time, the share is unlikely traded at cheap anymore. I prefer to accumulate slowly now despite facing higher risks.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Up_down
4,346 posts
Posted by Up_down > 2015-05-29 15:23 | Report Abuse
Please sell until below 2 as I want to collect more.